RedHill Biopharma (RDHL) Divestments (2013 - 2022)

RedHill Biopharma (RDHL) has 10 years of Divestments data on file, last reported at -$22000.0 in Q3 2022.

• Divestments for Q3 2022 came in at -$22000.0, up 99.74% year-over-year; the trailing twelve-month figure through Dec 2022 was $8.3 million (up 201.99% YoY), and the FY2025 annual result was $1.7 million, up 18888.89% from the prior year.
• Divestments grew to -$22000.0 in Q3 2022 per RDHL's latest filing, from -$163000.0 in the prior quarter.
• Over five years, Divestments peaked at $11.7 million in Q3 2019 and troughed at -$8.5 million in Q3 2021.
• A 5-year average of $1.3 million and a median of $573500.0 in 2018 frame the typical range for Divestments.
• The sharpest annual moves came in 2019 and 2022: Divestments plunged 2897.71% in 2019, then jumped 2093.02% in 2022.
• A 5-year view of Divestments shows it stood at $175000.0 in 2018, then sank by 2897.71% to -$4.9 million in 2019, then jumped by 260.36% to $7.9 million in 2020, then plunged by 55.46% to $3.5 million in 2021, then plunged by 100.63% to -$22000.0 in 2022.
• Business Quant data shows RDHL's Divestments at -$22000.0 in Q3 2022, -$163000.0 in Q2 2022, and $8.5 million in Q1 2022.